Sparta Infusion Set for Insulin— 510(k) K243841

Substantially Equivalent

Deka Research and Development

FDA 510(k) clearance K243841 for Sparta Infusion Set for Insulin, Substantially Equivalent on 2025-08-01. Applicant: Deka Research and Development. Device class: 2.

Clearance details

Applicant
Deka Research and Development
Product code
Code FPA
Device class
Class 2
Regulation
21 CFR 880.5440
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Manchester, NH, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code FPA

view all

More clearances from Deka Research and Development

view all

Adverse events under product code FPA

product code FPA
Death
95
Injury
14,421
Malfunction
125,815
Other
30
Total
140,361

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.